OR WAIT null SECS
Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.
This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.
Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.
March 01, 2021
Distribution of the first one-dose vaccine for COVID-19 to start in early March.
February 23, 2021
Aprecia's compression-free 3DP manufacturing platform and Glatt’s multiparticulate technologies offer solutions to pharmaceutical dosage design challenges.
February 17, 2021
The EC has granted marketing authorization to Celltrion Healthcare for its adalimumab biosimilar, Yuflyma (CT-P17).
February 03, 2021
Rapid growth in biologics and increasing complexity of new compounds are some of the factors driving development of innovative delivery solutions.
Advanced manufacturing technologies are available, but challenges need to be addressed.
February 02, 2021
The EC intends to get tougher on issues such as reliability of drug supplies, particularly essential medicines.
February 01, 2021
Best practices can help ensure supply chain flexibility and viability for biologic drugs in clinical trials.
January 29, 2021
The dispute between the European Commission (EC) of the European Union and pharmaceutical company AstraZeneca continues.
Although a necessity, companies must strike a critical balance between protecting innovations with IP and providing affordable access to medicines.
January 07, 2021
Intravacc and Cristal Therapeutics have entered into a strategic collaboration for the development of novel vaccine programs against human diseases.